Search

Author/Creator Behringer, Dirk

1. Baseline and interim PET‐based outcome prediction in peripheral T‐cell lymphoma: A subgroup analysis of the PETAL trial. Issue 3 (18th February 2020)

Authors:
Schmitz, Christine; Rekowski, Jan; Müller, Stefan P.; Hertenstein, Bernd; Franzius, Christiane; Ganser, Arnold; Bengel, Frank M.; Kroschinsky, Frank; Kotzerke, Jörg; La Rosée, Paul; Freesmeyer, Martin; Hoeffkes, Heinz‐Gert; Hertel, Andreas; Behringer, Dirk; Mesters, Rolf; Weckesser, Matthias; Mah...
Journal:
Hematological oncology
Issue:
Volume 38:Issue 3(2020)
Page Start:
244
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial. Issue 5 (May 2020)

Authors:
Pfisterer, Jacobus; Shannon, Catherine M; Baumann, Klaus; Rau, Joern; Harter, Philipp; Joly, Florence; Sehouli, Jalid; Canzler, Ulrich; Schmalfeldt, Barbara; Dean, Andrew P; Hein, Alexander; Zeimet, Alain G; Hanker, Lars C; Petit, Thierry; Marmé, Frederik; El-Balat, Ahmed; Glasspool, Rosalind; de...
Journal:
Lancet oncology
Issue:
Volume 21:Issue 5(2020)
Page Start:
699
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Sequential high-dose cytarabine and mitoxantrone (S-HAM) versus standard double induction in acute myeloid leukemia—a phase 3 study. Issue 12 (December 2018)

Authors:
Braess, Jan; Amler, Susanne; Kreuzer, Karl-Anton; Spiekermann, Karsten; Lindemann, Hans; Lengfelder, Eva; Graeven, Ullrich; Staib, Peter; Ludwig, Wolf-Dieter; Biersack, Harald; Ko, Yon-Dschun; Uppenkamp, Michael; Wit, Maike; Korsten, Stefan; Peceny, Rudolf; Gaska, Tobias; Schiel, Xaver; Behringer...
Journal:
Leukemia
Issue:
Volume 32:Issue 12(2018)
Page Start:
2558
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Sorafenib and everolimus in patients with advanced solid tumors and KRAS‐mutated NSCLC: A phase I trial with early pharmacodynamic FDG‐PET assessment. (21st May 2020)

Authors:
Nogova, Lucia; Mattonet, Christian; Scheffler, Matthias; Taubert, Max; Gardizi, Masyar; Sos, Martin L.; Michels, Sebastian; Fischer, Rieke N.; Limburg, Meike; Abdulla, Diana S.Y.; Persigehl, Thorsten; Kobe, Carsten; Merkelbach‐Bruse, Sabine; Franklin, Jeremy; Backes, Heiko; Schnell, Roland; Behri...
Journal:
Cancer medicine
Issue:
Volume 9:Number 14(2020)
Page Start:
4991
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗